Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$5.45 - $8.65 $1.38 Million - $2.19 Million
-253,538 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$4.34 - $11.43 $723,130 - $1.9 Million
-166,620 Reduced 39.66%
253,538 $1.88 Million
Q2 2020

Aug 17, 2020

BUY
$1.85 - $5.29 $77,233 - $220,846
41,748 Added 11.03%
420,158 $1.69 Million
Q1 2020

May 15, 2020

SELL
$1.24 - $4.35 $648,141 - $2.27 Million
-522,695 Reduced 58.01%
378,410 $961,000
Q4 2019

Feb 14, 2020

BUY
$2.3 - $5.12 $1.78 Million - $3.95 Million
771,906 Added 597.46%
901,105 $3.14 Million
Q3 2019

Nov 14, 2019

BUY
$4.63 - $12.15 $449,110 - $1.18 Million
97,000 Added 301.25%
129,199 $598,000
Q2 2019

Aug 13, 2019

SELL
$11.49 - $14.17 $2.87 Million - $3.54 Million
-249,996 Reduced 88.59%
32,199 $397,000
Q1 2019

May 14, 2019

BUY
$8.47 - $14.36 $441,287 - $748,156
52,100 Added 22.64%
282,195 $3.75 Million
Q4 2018

Feb 14, 2019

SELL
$7.18 - $8.83 $99,457 - $122,313
-13,852 Reduced 5.68%
230,095 $1.98 Million
Q3 2018

Nov 14, 2018

SELL
$5.92 - $8.35 $67,162 - $94,730
-11,345 Reduced 4.44%
243,947 $1.83 Million
Q2 2018

Aug 14, 2018

BUY
$4.86 - $6.24 $47,584 - $61,095
9,791 Added 3.99%
255,292 $1.52 Million
Q1 2018

May 15, 2018

BUY
$5.75 - $7.97 $24,725 - $34,271
4,300 Added 1.78%
245,501 $1.43 Million
Q4 2017

Feb 13, 2018

BUY
$4.46 - $6.45 $13,826 - $19,995
3,100 Added 1.3%
241,201 $1.42 Million
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.49 $130,817 - $202,306
36,850 Added 18.31%
238,101 $1.2 Million
Q2 2017

Nov 09, 2017

BUY
N/A
201,251
201,251 $813,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $81.8M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.